Skip to main content
. 2019 Oct 4;25(6):326–335. doi: 10.5761/atcs.oa.19-00093

Table 2. Operative characteristics.

Variable Overall
LVEF <50%
(n = 557)
Group 1
LVEF 40%–49%
(n = 294)
Group 2
LVEF 30%–39%
(n = 145)
Group 3
LVEF <30%
(n = 118)
P

Right-lateral mini-thoracotomy, n (%) 327 (58.7) 200 (68.0) 82 (56.6) 45 (38.1) <0.001
Isolated MV repair, n (%) 354 (63.5) 174 (59.1) 90 (62.1) 90 (76.2) 0.042
 Additional cryoablation, n (%) 166 (29.8) 100 (34) 44 (30.1) 22 (18.6) 0.009
 Additional ASD closure, n (%) 37 (6.6) 20 (6.8) 11 (7.6) 6 (5.1) 0.711
Annuloplasty ring model
 CE Physio Ring, n (%) 409 (73.4) 206 (70.1) 99 (68.3) 104 (88.1) <0.001
 CE Physio II Ring, n (%) 29 (5.2) 26 (8.8) 1 (0.7) 2 (1.7) <0.001
 IMR ETlogix Ring, n (%) 60 (10.7) 28 (9.5) 23 (15.9) 9 (7.6) 0.008
 Cosgrove Annuloplasty Band, n (%) 25 (4.4) 16 (5.4) 8 (5.5) 1 (0.8) 0.001
 MitralSolutions Annuloplasty Band, n (%) 3 (0.5) 3 (1.0) 0 (0) 0 (0)
 SJM Flexible Annuloplasty Ring, n (%) 5 (0.9) 2 (0.7) 3 (2.1) 0 (0) 0.655
 SJM Rigid Saddle Ring, n (%) 18 (3.2) 10 (10.4) 7 (4.8) 1 (0.8) 0.030
 SJM Seguin Annuloplasty Ring, n (%) 8 (1.4) 3 (1.0) 4 (2.8) 1 (0.8) 0.417
CPB time, min 111.7 ± 39.4 117.7 ± 41.2 106.3 ± 34.7 103.5 ± 38.0 0.001
Aortic cross-clamp time, min 62.9 ± 27.3 68.6 ± 28.5 59.8 ± 24.9 52.4 ± 23.6 <0.001

ASD: atrial septal defect; CE: Carpentier-Edwards; CPB: cardiopulmonary bypass; IMR: ischemic mitral regurgitation; LVEF: left ventricular ejection fraction; MV: mitral valve; SJM: St. Jude Medical